Get the Stockscreener App
1.45
2.03%
-0.03
Apyx Medical Corp stock is currently priced at $1.45, with a 24-hour trading volume of 58,357.
It has seen a -2.03% decreased in the last 24 hours and a +13.28% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.48 pivot point. If it approaches the $1.43 support level, significant changes may occur.
Previous Close:
$1.48
Open:
$1.4665
24h Volume:
58,357
Market Cap:
$50.23M
Revenue:
$52.35M
Net Income/Loss:
$-18.71M
P/E Ratio:
-3.0851
EPS:
-0.47
Net Cash Flow:
$-5.78M
1W Performance:
+9.85%
1M Performance:
+13.28%
6M Performance:
-40.57%
1Y Performance:
-50.68%
1D Range:
$1.42
$1.53
52W Range:
$1.21
$7.97
Apyx Medical Corp Stock (APYX) Company Profile
Name
Apyx Medical Corp
Sector
Industry
Phone
727 384 2323
Address
5115 Ulmerton Road, Clearwater, FL
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-22 | Initiated | Lake Street | Buy |
| Apr-02-19 | Reiterated | Dougherty & Company | Buy |
Apyx Medical Corp Stock (APYX) Latest News
Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results
Benzinga
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Gold Gains 1%; Micron Posts Upbeat Results
Benzinga
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Owens & Minor (OMI) Q4 Earnings Surpass Estimates
Zacks Investment Research
Insiders Buying Apyx Medical And 3 Other Stocks Under $3
Benzinga
Apyx Medical Corp Stock (APYX) Financials Data
Apyx Medical Corp (APYX) Revenue 2024
APYX reported a revenue (TTM) of $52.35 million for the quarter ending December 31, 2023, a +17.61% rise year-over-year.
Apyx Medical Corp (APYX) Net Income 2024
APYX net income (TTM) was -$18.71 million for the quarter ending December 31, 2023, a +19.28% increase year-over-year.
Apyx Medical Corp (APYX) Cash Flow 2024
APYX recorded a free cash flow (TTM) of -$5.78 million for the quarter ending December 31, 2023, a +72.84% increase year-over-year.
Apyx Medical Corp (APYX) Earnings per Share 2024
APYX earnings per share (TTM) was -$0.54 for the quarter ending December 31, 2023, a +19.40% growth year-over-year.
Apyx Medical Corp Stock (APYX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Goodwin Charles D. II | Chief Executive Officer |
Nov 14 '23 |
Buy |
1.57 |
50,000 |
78,500 |
90,000 |
| Waldman Lawrence | Director |
Jul 12 '23 |
Option Exercise |
2.97 |
5,338 |
15,854 |
5,338 |
| Hornsby Todd | Executive Vice President |
Jun 26 '23 |
Option Exercise |
1.77 |
15,000 |
26,550 |
15,000 |
| Hornsby Todd | Executive Vice President |
Jun 26 '23 |
Sale |
7.56 |
15,000 |
113,400 |
40 |
| Geraghty Michael | Director |
Jun 06 '23 |
Option Exercise |
2.79 |
10,000 |
27,900 |
27,500 |
About Apyx Medical Corp
Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide. The company markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. Its Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
1.69%
0.48%
Cap:
|
Volume (24h):